CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
The Antigen ASB4 on Cancer Stem Cells Serves as a Target for CTL Immunotherapy of Colorectal Cancer
Authors
Hata F
Hiratsuka H
+15 more
Hirohashi Y
Hongo A
Ishitani K
Kanaseki T
Kikuchi Y
Kochin V
Miyamoto S
Miyazaki A
Sato N
Takaya A
Takemasa I
Terui T
Tokita S
Torigoe T
Tsukahara T
Publication date
1 December 2018
Publisher
札幌医科大学
Abstract
網羅的なHLAリガンドーム解析により,がん幹細胞(cancer stem cell,CSC)に特異的なASB4由来のペプチドIV9を同定し,CSCを特異的に傷害可能なCTL免疫療法となることを示した.更にCSCを標的としたCTL免疫療法が再発予防として有用であることを明らかにした
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
SIKOR - Sapporo Medical University Information and Knowledge Repository / 札幌医科大学学術機関リポジトリ
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:sapmed.repo.nii.ac.jp:0001...
Last time updated on 17/10/2019